AstraZeneca PLC (LSE:AZN) shares rose 0.29% to 14,022p on 16 Nov 2026, leaving the global biopharmaceutical group marginally higher on the London market. A move of this kind is best viewed in context, because daily price changes can be influenced by market-wide sentiment, currency …
Convatec Group PLC (LSE:CTEC) shares rose 0.31% to 259p on 16 Nov 2026, leaving the medical products group marginally higher on the London market. Share price movements over a single session are frequently shaped by broader market conditions, changes in investor positioning and sector-wide …
Creo Medical develops devices used by clinicians in minimally invasive procedures. Its best-known product is the Speedboat device, which the company says has now been used in more than 10,000 procedures. It has also been commercialising its MicroBlate range, announcing in July 2026 that …
CRISM Therapeutics is a UK-focused clinical-stage company developing ChemoSeed, an implantable and biodegradable platform designed to deliver chemotherapy directly to tumours in a localised and sustained way. Its lead candidate is irinotecan-ChemoSeed, which is intended to be implanted during surgery for glioblastoma, an aggressive …
Diaceutics works with pharmaceutical companies to help precision medicines reach the patients who can benefit from them. Precision medicines often depend on a diagnostic test to identify eligible patients, and Diaceutics supports this process through data, analytics and services that span diagnostic regulatory planning, …
ECO Animal Health develops and sells medicines and vaccines for farm animals, with poultry an important market. Its established product is Aivlosin, an antibiotic used in livestock, and it is now building a range of poultry vaccines under the ECOVAXXIN brand. The group sells …
EDX Medical is a diagnosticsBusinesswith a portfolio of testing services covering cancer, infectious disease and wider health screening. Its announcements during 2026 describe a model built on partnerships, supplying tests developed in-house or by third parties to the NHS, private healthcare providers and employers.
Feedback develops digital health technology for the NHS. Its main product, Bleepa, is a clinical communication and care pathway platform that lets clinicians share information, including medical images, and manage patients along defined pathways.
Fusion Antibodies provides contract services to pharmaceutical and biotechnology companies, including antibody discovery, cell line development, transient gene expression and structural studies such as cryogenic electron microscopy. It also runs grant-funded projects with Queen's University Belfast.
Faron is based in Turku, Finland, and is listed on both AIM andNasdaqFirst North in Helsinki. Its lead asset, bexmarilimab, is a humanised antibody that targets Clever-1, a receptor found on certain immune cells. The company is studying it in blood cancers and solid …